MoonLake Immunotherapeutics MLTX Portugal — Long-Lived Assets
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's portugal — long-lived assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's portugal — long-lived assets?
- MoonLake Immunotherapeutics (MLTX) reported portugal — long-lived assets of $948K in Q1 2026.
- How has MoonLake Immunotherapeutics's portugal — long-lived assets changed year-over-year?
- MoonLake Immunotherapeutics's portugal — long-lived assets decreased by 22.5% year-over-year, from $1.22M to $948K.
- What does portugal — long-lived assets mean?
- This metric measures the total book value of non-current, tangible, and intangible assets located within the specified geographic segment. It reflects the company's capital investment and long-term commitment to infrastructure or intellectual property development in that region. Tracking this value assists in assessing the geographic concentration of the company's asset base and its potential for future operational capacity.